strategies

DEA Requirement for 8 Hours of CME on Addiction Medicine — OSU MedNet21 Can Help

by
OSU Wexner Medical Center logo

DEA Requirement for 8 Hours of CME on Addiction Medicine — OSU MedNet21 Can Help. In response to the opioid crisis, the U.S. Drug Enforcement Administration (DEA) now requires all DEA-registered practitioners to complete a one-time, 8-hour training on the treatment and management of patients with opioid or other substance use disorders. This requirement, effective June 27, 2023, applies to all clinicians applying for or renewing their DEA registration.

This training aligns with the Medication Access and Training Expansion (MATE) Act, a key federal initiative aimed at equipping clinicians with the knowledge to better manage addiction and reduce drug-related harm.

MedNet21 Can Help You Meet This Requirement

To support clinicians, MedNet21 offers several accredited web-based CME programs that collectively fulfill the DEA’s 8-hour mandate. Each module below covers critical aspects of substance use disorder education, from clinical management to stigma reduction:

📚 OSU MedNet21 CME Programs That Meet the DEA Requirement:

What You Need to Do

  • Complete a total of 8 hours of training using any combination of the programs listed above.
  • Retain your CME certificates as documentation in case of DEA audit.
  • This is a one-time requirement, not a recurring mandate.

If you have questions or need help accessing these programs, contact the MedNet21 team at at 614.293.3473.

Exploring Harm Reduction Strategies for People Who Use Drugs

by
OSU Wexner Medical Center logo

Exploring Harm Reduction Strategies for People Who Use Drugs. Learners can expect to learn about harm reduction, which is a philosophy, practice and approach to working with people who use drugs that focuses on prevention, risk-reduction and empowerment to let patients lead healthier and self-directed lives. The program will discuss examples of harm reduction strategies, evidence behind harm reduction and practical strategies for implementing harm reduction.

To discuss Harm reduction, we’ve invited one of Ohio State University’s Internal Medicine and Addiction experts. We’re pleased to introduce Associate Professor of Internal medicine Dr. Martin Fried. Marty is the founder and director of Ohio State University’s Primary Care Addiction Medicine clinic. He is also the co-founder of the CORE IM podcast.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Define Harm Reduction as a philosophy and multilayered set of strategies to promote the health, safety, autonomy, and dignity of people who use drugs (PWUD)
  • Identify public health approaches to Harm Reduction
  • Describe evidence-based harm reduction strategies to implement immediately in a primary care or hospital medicine practice

You’ll also learn about the following:

  • Incorporating into practice
  • Sustained Behavior Change
  • Monitoring for Benefit
  • Local Resources
  • Legal Matters

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Webcast Producer at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Multimodal Analgesia: Concepts and Strategies to Reduce Opioid Use

by

OSUWexnerbloglogo2014 CME Webcast Teaches on Multimodal Analgesia: Concepts and Strategies to Reduce Opioid Use. With the invention of the hypodermic syringe and hollow needle in 1850, morphine began to be used for surgical procedures and post-operative pain. However, many people became addicted to morphine so chemists set out to develop safer, more effective, and less addictive opioids. Thus heroin was created by the Bayer pharmaceutical company in 1898. That was followed by the synthesis of meperidine in 1939, methadone in 1946, and fentanyl in 1960. But all of these proved to be just as addictive as morphine. And this has left physicians in general and surgeons in particular with the dilemma of how do you relieve pain and suffering without causing the harm of addiction? Fortunately, we now have some guidance. Joining the webcast to tell us about strategies to treat pain while reducing opioid doses is OSU Professor of Plastic Surgery and the Past President of the American Society of Plastic Surgeons, Dr. Jeffrey Janis.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the current epidemiology and causes of the current opioid crisis in the United States; Understand the current opioid prescribing practices for perioperative pain; and DEVELOP intra-operative and post-operative pain management strategies to reduce opioid use.

You’ll also learn about the following:

  • Whether opioids used for pain management result in opioid addiction?
  • Opioid alternatives for pain management

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.